Longkou Union Chemical (301209)

Search documents
联合化学(301209) - 2023 Q1 - 季度财报
2023-04-23 16:00
Financial Performance - The company's operating revenue for Q1 2023 was ¥102,012,228.80, a decrease of 39.93% compared to ¥169,816,482.06 in the same period last year[5] - Net profit attributable to shareholders was ¥9,540,054.26, down 56.66% from ¥22,013,796.32 year-on-year[5] - The total profit for Q1 2023 was ¥10,556,882.14, down 57.89% from ¥25,067,759.65 in Q1 2022[8] - Basic earnings per share fell by 67.48% to ¥0.1193 from ¥0.3669 in the previous year[5] - Total operating revenue for Q1 2023 was ¥102,012,228.80, a decrease of 40% compared to ¥169,816,482.06 in the same period last year[16] - Net profit for Q1 2023 was ¥9,540,054.26, a decline of 56.7% from ¥22,013,796.32 in Q1 2022[18] - Earnings per share for Q1 2023 were ¥0.1193, compared to ¥0.3669 in the same period last year, reflecting a decrease of 67.5%[19] Cash Flow - The net cash flow from operating activities decreased by 21.09% to ¥19,397,759.48 from ¥24,582,429.12 in Q1 2022[5] - Cash inflow from operating activities was ¥64,209,911.03, down 38.8% from ¥105,021,420.64 in Q1 2022[21] - The total cash outflow from operating activities was CNY 44,812,151.55, compared to CNY 80,438,991.52 in the same period last year, indicating a reduction of about 44.4%[22] - The net cash flow from investment activities improved significantly to ¥19,709,745.70 from a negative ¥10,261,448.66 in the same period last year[9] - Cash inflow from investing activities totaled CNY 20,078,795.70, while cash outflow was CNY 369,050.00, resulting in a net positive cash flow[22] - The net increase in cash and cash equivalents for the quarter was CNY 38,863,475.04, compared to CNY 14,329,324.59 in Q1 2022, reflecting an increase of approximately 171.5%[22] - The ending balance of cash and cash equivalents was CNY 366,696,430.78, up from CNY 43,473,379.23 at the end of Q1 2022[22] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥768,011,215.32, a decrease of 2.04% from ¥784,022,630.65 at the end of the previous year[5] - The company's total current assets as of March 31, 2023, are 652,942,256.85 CNY, a decrease from 665,235,906.33 CNY at the beginning of the year[14] - The total liabilities for the company are 86,553,652.43 CNY, reduced from 112,236,051.89 CNY[14] - The company's total liabilities decreased to ¥90,034,437.50 from ¥115,852,467.03, a reduction of 22.3%[18] - Total equity attributable to shareholders increased to ¥677,976,777.82 from ¥668,170,163.62, an increase of 1.2%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,846[10] - The largest shareholder, Longkou Sunshine Chemical Co., Ltd., holds 42.83% of shares, totaling 34,260,000 shares[10] - The second-largest shareholder, Li Xiumei, owns 19.43% of shares, amounting to 15,540,000 shares[10] - The top ten shareholders include both natural persons and corporate entities, with significant ownership concentration[10] Other Financial Metrics - The weighted average return on equity decreased to 1.42% from 6.18% in the previous year[5] - Research and development expenses for Q1 2023 were ¥4,221,623.72, down 19.1% from ¥5,214,460.67 in Q1 2022[16] - The company reported a financial expense of -¥720,134.29, compared to a financial income of ¥221,592.71 in the previous year[18] - The company has no preferred shareholders as of the reporting period[12] - The company did not undergo an audit for the Q1 2023 report[23]
联合化学(301209) - 2022 Q4 - 年度财报
2023-04-23 16:00
Financial Performance - The company's operating revenue for 2022 was ¥541,984,420.48, a decrease of 1.80% compared to ¥551,940,509.90 in 2021[22]. - The net profit attributable to shareholders for 2022 was ¥64,154,917.71, down 4.55% from ¥67,213,172.95 in 2021[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥52,710,941.96, a decline of 16.55% from ¥63,167,072.87 in 2021[22]. - Cash flow from operating activities increased significantly by 120.50% to ¥71,056,614.54 from ¥32,224,961.15 in 2021[22]. - The total assets at the end of 2022 reached ¥784,022,630.65, representing a 58.84% increase from ¥493,586,657.15 at the end of 2021[22]. - The net assets attributable to shareholders increased by 93.62% to ¥668,170,163.62 from ¥345,085,209.37 in 2021[22]. - The basic earnings per share for 2022 was ¥0.9623, down 14.10% from ¥1.1202 in 2021[22]. - The weighted average return on equity decreased to 13.86% in 2022 from 21.58% in 2021, a drop of 7.72%[22]. - The company reported a total of ¥11,443,975.75 in non-recurring gains for 2022, compared to ¥4,046,100.08 in 2021[28]. - The company experienced a quarterly revenue decline throughout 2022, with the fourth quarter revenue at ¥102,621,090.12, down from ¥169,816,482.06 in the first quarter[24]. Dividend Distribution - The company plans to distribute a cash dividend of 1.80 RMB per 10 shares to all shareholders, based on a total of 80,000,000 shares[5]. - The cash dividend represents 100% of the total profit distribution amount, aligning with the company's profit distribution policy[189]. - The total distributable profit for the period is 134,546,675.73 CNY, indicating a healthy profit margin for future distributions[189]. Research and Development - The company has developed 9 invention patents and 14 utility model patents, with 4 invention patents currently under review[78]. - The company is focusing on developing high-performance organic pigments for specific applications, such as inkjet printing and food packaging, to enhance product competitiveness[98]. - The R&D team is also exploring new technologies for producing organic pigments that meet EU environmental standards, enhancing the company's green development strategy[98]. - The company aims to improve the performance of its products by developing specialized organic pigments tailored to customer specifications, such as the low-viscosity red pigment for UV applications[99]. - The focus on R&D and product innovation is expected to drive future growth and market expansion for the company[98]. Market and Product Focus - The company's main business focuses on the research, production, and sales of azo organic pigments and water-based inks, with over 200 customized pigment varieties developed since its establishment[55]. - The primary products include yellow, red, and orange azo organic pigments, which are predominantly used in the ink industry, requiring high transparency, color vividness, and tinting strength[55]. - The organic pigment industry in China has approximately 70 manufacturers, with an annual production of about 220,000 tons, accounting for around 60% of the global total production[64]. - The company is a major domestic supplier of organic pigments, maintaining a strategic partnership with DIC Corporation for over 10 years, serving other notable clients such as Yangzijiang, Hanghua, and Tianjin Toyo[65]. - The downstream industries of ink, coatings, and plastics are experiencing stable growth, which is expected to drive the demand for organic pigments[68]. Governance and Compliance - The company has established a complete governance structure, ensuring independence in assets, personnel, finance, institutions, and business operations[152]. - The financial department operates independently, maintaining a separate accounting system and bank accounts, with no shared accounts with controlling shareholders[155]. - The company has a dedicated human resources department, ensuring independent management of personnel and compensation[154]. - The company has established specialized committees under the board, including an audit committee that held 5 meetings during the reporting period[147]. - The independent directors actively participated in board meetings and contributed to improving corporate governance and protecting minority shareholders' rights[145]. Environmental Compliance - The company has complied with environmental protection regulations and has obtained the necessary pollution discharge permits[200]. - The company reported a total wastewater discharge of 29.6 tons, with no exceedances of discharge standards[200]. - The concentration of COD in wastewater from the southern plant was 82.2 mg/L, below the standard[200]. - The concentration of ammonia nitrogen in wastewater from the northern plant was 1.37 mg/L, also compliant with standards[200]. - The company has implemented measures to manage pollutant emissions in accordance with environmental assessments[200]. Operational Efficiency - The company has implemented a production model based on its own manufacturing, with a monthly production plan aligned with sales forecasts and inventory levels[59]. - The company utilizes a PLC online control system for automated production processes, enhancing precision in material handling and reaction conditions[59]. - The company is integrating traditional production processes with new technologies, aiming for full automation in production processes[83]. - The company has established a stable supplier management system, with raw material procurement primarily from Shandong and Jiangsu-Zhejiang-Shanghai regions, influenced by market price fluctuations[58]. Financial Management - The company raised a total of RMB 299 million through the issuance of 20 million shares at a price of RMB 14.95 per share, with a net amount of RMB 258.32 million after deducting issuance costs[116]. - The company has committed to an annual production project of 8,000 tons of organic pigments, with a total investment of RMB 201.94 million, and the project is expected to be completed by August 2024[118]. - The company has not engaged in any significant equity or derivative investments during the reporting period[111][112]. - The company has not capitalized any R&D expenditures, maintaining a 0.00% capitalization rate for the past three years[101]. Employee Management - The company had a total of 378 employees at the end of the reporting period, with 265 in production, 11 in sales, 65 in technology, 9 in finance, and 28 in administration[183]. - The company has a competitive salary policy, providing benefits such as meal allowances, accommodation, holiday benefits, and annual health checks[184]. - The educational background of employees includes 280 with high school or below, 72 with associate degrees, 24 with bachelor's degrees, and 2 with master's degrees[183]. - The company has established a comprehensive training system to enhance employee skills and ensure compliance with operational standards[186].
联合化学(301209) - 2022 Q3 - 季度财报
2022-10-23 16:00
Financial Performance - The company's operating revenue for Q3 2022 was ¥114,275,248.83, a decrease of 10.43% compared to the same period last year[4] - The net profit attributable to shareholders for Q3 2022 was ¥10,287,614.60, down 19.14% year-on-year[4] - The basic earnings per share for Q3 2022 was ¥0.1286, reflecting a decline of 39.35% compared to the previous year[4] - The company's net profit for the year-to-date was ¥51,860,012.84, reflecting a growth of 10.01% compared to the same period last year[4] - Total operating revenue for the third quarter of 2022 reached CNY 439,363,330.36, an increase of 12.0% compared to CNY 392,113,873.49 in the same period last year[19] - Net profit for the third quarter of 2022 was CNY 51,860,012.84, representing a growth of 9.0% from CNY 47,139,991.69 in the previous year[21] - The total comprehensive income for the third quarter was CNY 51,860,012.84, reflecting a growth of 9.0% compared to CNY 47,139,991.69 in the previous year[21] Assets and Liabilities - Total assets at the end of Q3 2022 reached ¥806,132,597.98, an increase of 63.32% from the end of the previous year[4] - Total assets increased to CNY 806,132,597.98, up from CNY 493,586,657.15, indicating a growth of 63.5% year-over-year[18] - The company's total liabilities amounted to CNY 150,867,537.92, a slight increase from CNY 148,501,447.78, reflecting a growth of 1.0%[18] - The equity attributable to shareholders of the parent company rose to CNY 655,265,060.06, up from CNY 345,085,209.37, marking an increase of 90.0%[18] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥70,792,488.66, up 106.39%[4] - Operating cash flow for the period reached ¥70,792,488.66, a significant increase of 106.5% compared to ¥34,299,939.03 in the previous period[22] - Total cash inflow from operating activities was ¥326,731,404.24, up from ¥221,026,050.44, reflecting a growth of 47.9%[22] - Cash outflow from operating activities increased to ¥255,938,915.58 from ¥186,726,111.41, representing a rise of 37.0%[22] - The company experienced a net increase in cash and cash equivalents of ¥311,018,984.32, compared to a decrease of ¥499,074.52 in the prior period[23] - The ending balance of cash and cash equivalents stood at ¥340,163,038.96, a substantial increase from ¥25,731,297.14 at the end of the previous period[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,286[11] - The largest shareholder, Longkou Sunshine Chemical Co., Ltd., holds 42.83% of shares, totaling 34,260,000 shares[11] - The total number of preferred shareholders is not applicable, indicating no preferred shares were issued[13] - The company has no shareholders participating in margin trading among the top ten shareholders[12] Expenses - The company’s sales expenses increased by 47.81% to ¥3,445,518.63, primarily due to new product EU registration fees[8] - The company’s financial expenses showed a dramatic increase of 1906.52%, resulting in a net financial income of -¥7,939,996.91[9] - Research and development expenses for the period were CNY 15,609,724.20, compared to CNY 14,008,075.86 in the previous year, showing an increase of 11.4%[19] - The total operating costs for the third quarter were CNY 385,614,359.99, an increase of 13.6% from CNY 339,558,672.31 in the previous year[19] - The company reported a decrease in income tax expenses to CNY 6,621,113.93 from CNY 8,695,638.78, a reduction of 23.9%[21] Investments - The company has invested in fixed assets totaling ¥96,290,762.92 as of September 30, 2022, compared to ¥92,291,598.79 at the beginning of the year[16] - The company has a long-term investment in construction projects amounting to ¥6,413,548.75, a significant increase from ¥658,407.08 at the beginning of the year[16] - The company’s investment cash outflow decreased by 44.62% to ¥36,000,000.00, attributed to reduced purchases of financial products[9] IPO and Share Issuance - The company issued 20 million shares in its public offering, which began trading on August 25, 2022[14] Audit Status - The report was not audited, indicating that the figures presented are preliminary and subject to change[24]
联合化学(301209) - 2022 Q2 - 季度财报
2022-08-29 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was ¥325,088,081.53, representing a 22.89% increase compared to ¥264,534,546.49 in the same period last year[22]. - Net profit attributable to shareholders was ¥41,572,398.24, up 20.79% from ¥34,417,610.52 year-on-year[22]. - The net cash flow from operating activities surged by 340.24% to ¥61,809,039.38, compared to ¥14,039,878.68 in the previous year[22]. - Basic earnings per share increased by 21.05% to ¥0.69, compared to ¥0.57 in the same period last year[22]. - The company's revenue for the reporting period reached ¥325,088,081.53, representing a year-on-year increase of 22.89% compared to ¥264,534,546.49 in the previous year[50]. - The total operating revenue for the first half of 2022 was CNY 325,088,081.53, an increase of 22.8% compared to CNY 264,534,546.49 in the same period of 2021[146]. - The net profit for the first half of 2022 reached CNY 41,572,398.24, representing a growth of 20.7% from CNY 34,417,610.52 in the previous year[148]. - The total operating costs amounted to CNY 278,846,917.02, up from CNY 225,631,937.49, reflecting a year-on-year increase of 23.5%[146]. - The company's total assets increased to CNY 571,518,909.17, compared to CNY 493,586,657.15 at the end of the previous period, marking a growth of 15.8%[144]. - The total liabilities rose to CNY 184,456,657.68, up from CNY 148,501,447.78, indicating an increase of 24.2%[144]. Research and Development - Research and development investment increased by 26.07% to ¥11,625,846.50 from ¥9,221,571.05 in the previous year[50]. - Research and development expenses for the first half of 2022 were CNY 11,625,846.50, compared to CNY 9,221,571.05 in the same period last year, reflecting a 26.1% increase[147]. - Research and development expenses accounted for 6% of total revenue, reflecting the company's commitment to innovation[156]. Market and Industry Position - The company's main business focuses on the research, production, and sales of azo organic pigments and water-based inks, with over 200 customized pigment products developed for various ink types[30]. - The organic pigment industry in China has a production capacity of approximately 220,000 tons, accounting for about 60% of global output, positioning China as a leading producer[37]. - The downstream industries, including inks, coatings, and plastics, are experiencing stable growth, driving demand for organic pigments[41]. - The shift of organic pigment production from Europe and the US to Asia continues, with Chinese companies becoming key suppliers to major international chemical firms[42]. - The company aims to explore potential demand from existing major clients and expand its supply capabilities as new investment projects reach full production[40]. - The company has initiated a strategic partnership with a leading chemical firm to enhance its supply chain efficiency[156]. Cash Flow and Liquidity - The company's cash flow from operating activities surged by 340.24% to ¥61,809,039.38, primarily due to increased cash receipts from foreign sales[50]. - The company's cash and cash equivalents increased significantly by 694.85% to ¥49,822,636.43 from a negative balance of ¥8,375,627.45 in the previous year[50]. - The cash and cash equivalents at the end of the period totaled CNY 78,966,691.07, compared to CNY 17,854,744.21 at the end of the previous year, marking an increase of approximately 341%[151]. - The net increase in cash and cash equivalents for the period was CNY 49,822,636.43, a turnaround from a decrease of CNY 8,375,627.45 in the same period last year[151]. Environmental and Safety Management - The company has established multiple environmental protection facilities, ensuring pollutant emissions are within the treatment capacity of these facilities[68]. - The company is classified as a key pollutant discharge unit, with specific measures in place to manage and treat waste[82]. - The company operates a wastewater treatment plant with a capacity of 1,500 tons/day at the South Plant and 4,500 tons/day at the North Plant, both running normally[83]. - The company has implemented a comprehensive environmental management system, ensuring compliance with national environmental laws and regulations[92]. - The company has developed an emergency response plan for environmental risks and hazardous waste, which is regularly updated and practiced[90]. - The company reported no safety production accidents during the reporting period and complied with safety regulations[100]. Shareholder and Corporate Governance - The company plans not to distribute cash dividends or issue bonus shares[5]. - The company has not implemented any employee incentive plans during the reporting period[79]. - The largest shareholder, Longkou Sunshine Chemical Co., Ltd., holds 57.10% of shares, totaling 34,260,000 shares[129]. - The total number of common shareholders at the end of the reporting period is 5[129]. - There were no significant related party transactions or major contracts during the reporting period[109][122]. Financial Reporting and Compliance - The financial report for the first half of 2022 has not been audited[140]. - The financial statements were approved by the board of directors on August 29, 2022[161]. - The financial statements are prepared in accordance with the Accounting Standards for Business Enterprises, reflecting the company's financial position and operating results accurately[167].